Arch Venture Fund Vii Lp, Ten Percent Owner at Juno Therapeutics, holds 11.55M shares in Juno Therapeutics (Ticker: JUNO), holds ― shares in Pulmatrix (Ticker: PULM), holds 5.73M shares in 908 Devices (Ticker: MASS).
What is the percentage of profitable transactions made by Arch Venture Fund Vii Lp?
The percentage of profitable transactions made by Arch Venture Fund Vii Lp is 50%.
What is the average return per transaction made by Arch Venture Fund Vii Lp?
The average return per transaction made by Arch Venture Fund Vii Lp is -79.40%.
What stocks does Arch Venture Fund Vii Lp hold?
Arch Venture Fund Vii Lp holds: JUNO, PULM, SYRS, MASS, AGIO, SAGE, BLUE, RCPT stocks.
What was Arch Venture Fund Vii Lp’s latest transaction?
Arch Venture Fund Vii Lp latest transaction was an Uninformative Sell of ―.
What was Arch Venture Fund Vii Lp's most profitable transaction?
Arch Venture Fund Vii Lp’s most profitable transaction was an Informative Buy of JUNO stock on December 18, 2014. The return on the trade was 85.90%.
What is Arch Venture Fund Vii Lp's role in Juno Therapeutics?
Arch Venture Fund Vii Lp's role in Juno Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.